Gene · 917
Papers1,874
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,874
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of a Molecular-Subtype-Associated Immune Prognostic Signature That Can Be Recognized by MRI Radiomics Features in Bladder Cancer. | Bioengineering (Basel) | 2023 | 36978709 | PubTator, text mining | PubMed |
| A novel DNA methylation-related gene signature for the prediction of overall survival and immune characteristics of ovarian cancer patients. | J Ovarian Res | 2023 | 36978087 | PubTator, text mining | PubMed |
Spatiotemporally deciphering the mysterious mechanism of persistent HPV-induced malignant transition and immune remodelling from HPV-infected normal cervix, precancer to cervical cancer: Integrating single-cell RNA-sequencing and spatial transcriptome. | Clin Transl Med | 2023 | 36967539 | PubTator, text mining | PubMed |
| Tissue specific imprinting on innate lymphoid cells during homeostasis and disease process revealed by integrative inference of single-cell transcriptomics. | Front Immunol | 2023 | 36960063 | PubTator, text mining | PubMed |
| A generalized non-linear model predicting efficacy of neoadjuvant therapy in HER2+ breast cancer. | iScience | 2023 | 36950120 | PubTator, text mining | PubMed |
| Exploring heterogeneity of tumor immune cells and adrenal cells in aldosterone-producing adenomas using single-cell RNA-seq and investigating differences by sex. | Heliyon | 2023 | 36942259 | PubTator, text mining | PubMed |
| Opto-APC: Engineering of cells that display phytochrome B on their surface for optogenetic studies of cell-cell interactions. | Front Mol Biosci | 2023 | 36936981 | PubTator, text mining | PubMed |
| A theoretical framework of immune cell phenotypic classification and discovery. | Front Immunol | 2023 | 36936975 | PubTator, text mining | PubMed |
| Transcriptional analysis links B cells and TERT expression to favorable prognosis in head and neck cancer. | PNAS Nexus | 2023 | 36909826 | PubTator, text mining | PubMed |
| Strength of CAR signaling determines T cell versus ILC differentiation from pluripotent stem cells. | Cell Rep | 2023 | 36906850 | PubTator, text mining | PubMed |
| Overexpression of Potential Markers of Regulatory and Exhausted CD8+ T Cells in the Peripheral Blood Mononuclear Cells of Patients with B-Acute Lymphoblastic Leukemia. | Int J Mol Sci | 2023 | 36901957 | PubTator, text mining | PubMed |
| Subtyping based on immune cell fractions reveal heterogeneity of cardiac fibrosis in end-stage heart failure. | Front Immunol | 2023 | 36875078 | PubTator, text mining | PubMed |
| Identification of key candidate genes and pathways in rheumatoid arthritis and osteoarthritis by integrated bioinformatical analysis. | Front Genet | 2023 | 36861127 | PubTator, text mining | PubMed |
| Fine particulate matter (PM2.5)-induced pulmonary oxidative stress contributes to changes in the plasma lipidome and liver transcriptome in mice. | Toxicol Sci | 2023 | 36857595 | PubTator, text mining | PubMed |
| Dysregulation of innate cell types in the hepatic immune microenvironment of alcoholic liver cirrhosis. | Front Immunol | 2023 | 36845083 | PubTator, text mining | PubMed |
| Autoimmune Lymphoproliferative Syndrome (ALPS) Disease and ALPS Phenotype: Are They Two Distinct Entities? | Hemasphere | 2023 | 36844186 | PubTator, text mining | PubMed |
| Combined Analysis of the Whole Transcriptome of Piglets Infected with SADS-CoV Virulent and Avirulent Strains. | Microorganisms | 2023 | 36838374 | PubTator, text mining | PubMed |
| Synchronous Breast and Cervical Carcinoma: A Genetic Point of View. | Biomedicines | 2023 | 36831061 | PubTator, text mining | PubMed |
| Single-cell pair-wise relationships untangled by composite embedding model. | iScience | 2023 | 36824286 | PubTator, text mining | PubMed |
| The Prognostic Model Established by the Differential Expression Genes Based on CD8+ T Cells to Evaluate the Prognosis and the Response to Immunotherapy in Osteosarcoma. | Mediators Inflamm | 2023 | 36816742 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/917/papers?page=16